HRT Financial’s Anbio Biotechnology NNNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$131K Buy
+20,935
New +$178K ﹤0.01% 4034
2025
Q4
– Sell
-6,013
Closed -$223K – 4287
2025
Q3
$223K Buy
+6,013
New +$270K ﹤0.01% 2357

Other funds holding NNNN

HRT Financial's NNNN Position: Q3 2026 in Review

HRT Financial opened a new position in Anbio Biotechnology (NNNN) in Q3 2026: 20,935 shares worth $131K. The stake represents ﹤0.01% of the portfolio and ranks #4034 among its holdings. This is a return to the name: HRT Financial previously reported a position in NNNN as recently as Q3 2025.

HRT Financial first reported a position in NNNN in Q3 2025 and has held it in 2 quarters since. The position peaked at $223K in Q3 2025. 14 funds tracked by Wall St. Rank hold NNNN as of Q3 2026.

  • HRT Financial held 20,935 shares of Anbio Biotechnology worth $131K as of Q3 2026.
  • Anbio Biotechnology was a new HRT Financial position in Q3 2026.
  • Anbio Biotechnology made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4034 holding.
  • HRT Financial first reported a position in Anbio Biotechnology in Q3 2025 and has held it in 2 quarters since.
  • HRT Financial's Anbio Biotechnology position peaked at $223K in Q3 2025.
  • 14 funds tracked by Wall St. Rank held Anbio Biotechnology as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.